Where is RBQM Heading in The Future With AI?

Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials. With experience at both CluePoints and Veeva, Young discusses AI’s role, transparency, and the future of risk management in clinical trials.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Blog

The Hidden Inspection Risk in Your Medical and Safety Review Workflow

You have just been told an inspection is coming. Your team’s first reaction is not to...

Blog

Why Medical and Safety Review Is One of the Last Manual Workflows in Clinical Trials

It is Tuesday morning. You have a data cut from last night, three studies to review...

Blog

Turning Oversight into Evidence: How to Prove Your Decisions at Any Point in a Trial

Clinical trial oversight is changing. For years, Sponsors have focused on demonstrating that oversight activities occurred:...